Restored to trading, shares in Clean Power Hydrogen PLC (AIM:CPH2) slumped 90% this week, the reckoning for problems dating back to late May, when its hydrogen electrolyser failed during factory acceptance testing.
The damage was so severe the unit was deemed irreparable. A planned fundraiser was shelved and the contract subsequently terminated.
The company has now secured new investment of up to £7.5 million, but at a severe discount. New shares were issued at 1.5p each, a massive haircut given the stock traded at 13.6p before the suspension.
The capital injection came with a boardroom reshuffle as Clean Power pivots to a capital-light model focused on licensing its proprietary membrane-free electrolyser technology. Whatever that means.
In all, a chastening experience for all involved. One tiny glimmer: management is working with insurers to assess the claim and a potential interim payment.
Winning streak ends on a quiet week
Turning to the wider market, the AIM All-Share's two-week winning streak came to an end. It fell 1.6% to 765.13 on what, frankly, was a dull week for small-cap news. The FTSE 100 kept it company on the way down, off 1.8%.
There was another flurry of fundraisers before the City packs its bags for the traditional summer lull.
The mark-downs were in some cases brutal (and mathematically symmetric, funnily enough). The theory goes that a short, sharp shock to the share price buys longer-term value creation. The theory doesn't always hold.
Fundraisers come thick and fast
By far the most ambitious round came from EnSilica PLC (AIM:ENSI), which designs chips for the satellite communications, industrial and healthcare industries.
It raised about £14 million through an oversubscribed placing and subscription, giving it fresh firepower to accelerate new products, projects and a growing contract pipeline. The shares ended the week a modest 3% lower. As these things go, a result.
Phoenix Copper Ltd (AIM:PXC, OTCQX:PXCLF, FRA:5HR), off 58%, brought in £2.1 million net to repay its short-term debt facility and fund process design engineering.
Quadrise, which is developing a green fuel additive for the shipping industry, launched a £2.4 million round as it pushes projects towards commercial supply.
The proceeds will support commercial marine trials with MSC and Cargill, including work towards a supply hub in Antwerp. There are also projects with OCP in Morocco, Valkor in Utah and industrial power opportunities in the Americas. Quite the itinerary. The stock fell 42%.
GoldStone Resources (AIM:GRL) bucked the trend, advancing 23% after the gold miner secured £3.51 million from Persistence Gold Group, which takes a 20.96% stake at 1p a share.
Investors welcomed the funding certainty. Proceeds will expand drilling at the Homase mine in Ghana, grow the resource base and bolster working capital. Persistence gains the right to nominate a director, with industry veteran Jeff Malaihollo expected to join the board.
Takeover talk sends Safestay (AIM:SSTY) soaring
Now, onto the risers proper. Safestay (AIM:SSTY) shot up 122% after the hostel operator confirmed talks with Infill Capital Partners over a possible £41 million take-private offer. The approach may include a cash offer and an unlisted share alternative. Not bad for a bed for the night.
Victoria PLC (AIM:VCP) rose 25% after the flooring group agreed a refinancing that cuts senior secured debt and preferred share liabilities by more than £300 million. The deal with Koch and noteholders removes near-term dilution risk, trims annual finance costs by £34 million and pushes maturities out to 2031. Trading, meanwhile, shows year-on-year revenue growth.
Insig AI PLC (AIM:INSG) added 20% after chief executive Richard Bernstein proposed investing £250,000 at 15p a share, a premium to the market price. Nothing signals confidence like a CEO reaching for his own chequebook. The data analytics firm expects revenue to more than double to £1.65 million in financial year 2027, reaching operating profitability, and is weighing a NASDAQ dual listing.
IXICO delivers away from the limelight
And finally, IXICO PLC (LSE:IXI, OTC:PHYOF, FRA:PYPB) is quietly getting on with it away from the limelight, with plenty of headroom if the broker's price target proves correct. Shares in the neuroscience imaging specialist rose 8% to 9.15p this week after it lifted revenue guidance for the year.
It now expects at least £8 million, up 22% year-on-year and ahead of market expectations, having previously pointed to £7.5 million. The AI-driven contract research group credited contract extensions and a broadening client base.
Chief executive Bram Goorden said the performance validated a strategy launched in 2024. Broker Cavendish believes the new TechBio strategy can deliver high-margin, recurring revenues alongside the established imaging business.
Its price target is 26p, nearly three times the current share price.
